SANDOZ CANADA INC. C/O UPS SCS — Sitagliptin Importer Profile
Pharmaceutical Importer · #3 buyer for Sitagliptin · $2.6M import value · 70 shipments · CANADA · DGFT Verified
SANDOZ CANADA INC. C/O UPS SCS is the #3 importer of Sitagliptin from India with $2.6M in import value and 70 verified shipments. SANDOZ CANADA INC. C/O UPS SCS holds a 4.0% market share in Sitagliptin imports based in CANADA. The company sources from 1 verified supplier across 43 formulations shipped to 1 country. Overall, SANDOZ CANADA INC. C/O UPS SCS imports 3 pharmaceutical products worth $5.5M across 3 therapeutic categories.
SANDOZ CANADA INC. C/O UPS SCS — Sitagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sitagliptin to SANDOZ CANADA INC. C/O UPS SCS?
Verified from 70 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SANDOZ PRIVATE LIMITED | $2.6M | 70 | 100.0% |
SANDOZ CANADA INC. C/O UPS SCS sources Sitagliptin from 1 verified Indian supplier based on 70 customs records. The primary supplier is SANDOZ PRIVATE LIMITED accounting for 100.0% of imports.
How Does SANDOZ CANADA INC. C/O UPS SCS Compare to Nearest Sitagliptin Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | NEXT PHARMA LOGISTICS GMBH | GERMANY | $4.3M | 86 | $50.0K |
| 4 | SUDAIR PHARMA COMPANY | SAUDI ARABIA | $3.2M | 78 | $41.6K |
| 3 | SANDOZ CANADA INC. C/O UPS SCS ★ | CANADA | $3.0M | 61 | $50.0K |
| 7 | NEXTPHARMA LOGISTICS GMBH | GERMANY | $2.8M | 160 | $17.3K |
| 10 | AMB HK ENTERPRISES INC. | PHILIPPINES | $1.7M | 34 | $50.0K |
SANDOZ CANADA INC. C/O UPS SCS ranks #3 among 575 Sitagliptin importers from India. Average shipment value of $50.0K compared to the market average of $44.6K. The closest competitors by value are NEXT PHARMA LOGISTICS GMBH and SUDAIR PHARMA COMPANY.
Where Does SANDOZ CANADA INC. C/O UPS SCS Import Sitagliptin To?
Destination countries from 70 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $2.6M | 70 | 100.0% |
SANDOZ CANADA INC. C/O UPS SCS imports Sitagliptin to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $2.6M.
What Sitagliptin Formulations Does SANDOZ CANADA INC. C/O UPS SCS Import?
| Formulation | Value | Shipments |
|---|---|---|
| Material No. - 44101245 SITAGLIPTIN SDZ | $250.5K | 6 |
| SITAGLIPTIN SDZ 100MG 100FCT BO CA MATER | $200.0K | 4 |
| SIV-SITAGLIPTIN 100MG 100FCT BO CA MATERIAL NO. - 44106175 | $193.1K | 4 |
| SITAGLIPTIN SDZ 50MG 100FCT BO CA MATERI | $150.0K | 3 |
| SITAGLIPTIN SDZ 100MG 500FCT BO CA MATER | $119.5K | 3 |
| Material No. - 44101256 SITAGLIPTIN SDZ | $101.9K | 3 |
| Material No: 44101256 SITAGLIPTIN SDZ 10 | $100.0K | 2 |
| SIV-SITAGLIPTIN 100MG 500FCT BO CA MATER | $100.0K | 2 |
| SIV-SITAGLIPTIN 100MG 100FCT BO CA MATER | $100.0K | 2 |
| Material No 44101245 SITAGLIPTIN SDZ100MG 100FCT BO CA | $100.0K | 2 |
SANDOZ CANADA INC. C/O UPS SCS imports 43 distinct Sitagliptin formulations from India. The top formulation is Material No. - 44101245 SITAGLIPTIN SDZ with 6 shipments worth $250.5K.
Regulatory Requirements: Importing Sitagliptin into Canada
What SANDOZ CANADA INC. C/O UPS SCS and other importers must comply with to import Sitagliptin from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Sitagliptin
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sitagliptin from India and How Much Does SANDOZ CANADA INC. C/O UPS SCS Import?
India exported $25.7M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. SANDOZ CANADA INC. C/O UPS SCS imports $2.6M of this total, accounting for 4.0% of India's Sitagliptin exports with 70 shipments from CANADA. This is verified from 70 customs shipment records covering 43 distinct formulations.
What Is the Average Order Value for SANDOZ CANADA INC. C/O UPS SCS's Sitagliptin Imports?
SANDOZ CANADA INC. C/O UPS SCS's average Sitagliptin order value is $37.6K per consignment, based on 70 shipments totaling $2.6M. SANDOZ CANADA INC. C/O UPS SCS is based in CANADA and ranks #3 among all Sitagliptin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sitagliptin to SANDOZ CANADA INC. C/O UPS SCS?
SANDOZ CANADA INC. C/O UPS SCS sources Sitagliptin from 1 verified Indian supplier: SANDOZ PRIVATE LIMITED ($2.6M, 100.0%). This is based on 70 customs records.
How Does SANDOZ CANADA INC. C/O UPS SCS Compare to Other Sitagliptin Importers?
SANDOZ CANADA INC. C/O UPS SCS ranks #3 among 575 Sitagliptin importers from India with a 4.0% market share. The top 3 importers are NEXT PHARMA LOGISTICS GMBH ($4.3M), SUDAIR PHARMA COMPANY ($3.2M), SANDOZ CANADA INC. C/O UPS SCS ($3.0M). SANDOZ CANADA INC. C/O UPS SCS processed 70 shipments from CANADA.
About SANDOZ CANADA INC. C/O UPS SCS
SANDOZ CANADA INC. C/O UPS SCS imports 3 products worth $5.5M. Beyond Sitagliptin, top products include Tacrolimus, Dapagliflozin. View the complete SANDOZ CANADA INC. C/O UPS SCS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SANDOZ CANADA INC. C/O UPS SCS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SANDOZ CANADA INC. C/O UPS SCS's capped import value divided by total capped export value for Sitagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 70 individual customs records matching SANDOZ CANADA INC. C/O UPS SCS importing Sitagliptin, covering 43 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Import Data for SANDOZ CANADA INC. C/O UPS SCS
Access order-level details, pricing data, supplier connections, and competitive analysis for SANDOZ CANADA INC. C/O UPS SCS's Sitagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SANDOZ CANADA INC. C/O UPS SCS
Full Company Profile →
3 products · $5.5M total trade · 3 categories
SANDOZ CANADA INC. C/O UPS SCS × Sitagliptin
Verified from customs records
Company Overview
Top Products by SANDOZ CANADA INC. C/O UPS SCS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SANDOZ CANADA INC. C/O UPS SCS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current order-level data, contact TransData Nexus.